SCHEMBL4010086

SCHEMBL4010086

COC(=O)Oc1c(CC(C)C)nc(-c2ccc(Cl)cc2)nc1OC(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.46
NAMPT P43490 1/20 0.38
CTRC Q99895 1/20 0.37
ADORA3 P0DMS8 3/20 0.37
DHPS P49366 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 3/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
CNR1 P21554 1/20 0.35
SCN5A Q14524 2/20 0.34
SCN10A Q9Y5Y9 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4015692 0.88 DHPS (0.40) ATMNAMPTCTRCADORA3DHPS
SCHEMBL4007716 0.85 ADORA3 (0.39) NAMPTADORA3SMN1; SMN2MEN1KMT2A
SCHEMBL8031508 0.83 ATM (0.46) ATMNAMPTCTRCADORA3SMN1; SMN2
SCHEMBL4009344 0.81 NPSR1 (0.39) NAMPTADORA3SMN1; SMN2MEN1KMT2A
SCHEMBL8031087 0.81 ATM (0.51) ATMNAMPTCTRCSMN1; SMN2MEN1
SCHEMBL4014816 0.79 ATM (0.45) ATMNAMPTADORA3DHPSSMN1; SMN2
SCHEMBL4010260 0.75 ATM (0.45) ATMADORA3SMN1; SMN2LMNARAB9A
SCHEMBL4007862 0.74 NAMPT (0.38) ATMNAMPTCTRCADORA3SMN1; SMN2
SCHEMBL4009395 0.74 CNR1 (0.41) NAMPTCNR1
SCHEMBL4007725 0.74 ADORA3 (0.39) NAMPTADORA3SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080248-A1 SUBSTITUTED 2-PHENYLPYRIMIDINE-5-CARBOXYLIC ACIDS AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-02 WO disclosed